CK20-004, Chicago Prevention and Intervention Epicenter III (CPIE-III)
CK20-004, Chicago Prevention and Intervention Epicenter III (CPIE-III)
批准号:
10651677
负责人:
Mary Katherine Hayden
金额:
$167.88万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-06-01 至 2026-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Core Project Summary
The Chicago Prevention and Intervention Epicenter will focus on objectives promoted by CDC. Through our
core projects we will make epidemiologic and basic science discoveries and technological innovations
translatable into strategies to prevent spread of antimicrobial-resistant organisms within facilities and regionally
across the web of interconnected facilities. To control endemic antimicrobial-resistant pathogens, and to
mitigate emerging, novel mechanisms of resistance, a bundle of interventions is needed and applied across
the spectrum of healthcare facilities. We propose an ambitious portfolio of projects in hospitals, long-term acute
care hospitals (LTACHs), and skilled nursing facilities. Our projects span the infection control domains of
interest to CDC, annotated by the following six core projects (abridged for this summary):
Project 1: Predictive modeling to identify patients at high-risk for MDROs to inform Illinois' XDRO registry.
Population, hospital and LTACH patients. Domain, regional control including long-term care facilities.
Project 2: Regional active MDRO surveillance with genomic analysis. Population, hospitals, LTACHs and
nursing homes. Domain, containment of novel resistance.
Project 3: Geospatial, ecologic, and clinical risk factors for community-associated ESBL-producers.
Population, emergency department and ambulatory patients of two large, urban health systems. Domain,
community-associated antimicrobial-resistant infections.
Project 4: Genomic epidemiology of MDRO transmission in ICUs. Population, hospital ICU patients. Domain,
applying innovative research methodology to evaluate MDRO transmission.
Project 5: Adverse health outcomes associated with microbiota disruption. Population, medical ICU patients.
Domains, effects of antibiotic use and diagnostics—evaluating measures of the microbiome.
Project 6: Generate and export reports on antimicrobial use metrics from a national common data model.
Population, hospital patients. Domain, Antimicrobial stewardship
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CK20-004, Chicago Prevention and Intervention Epicenter III (CPIE-III)
-
批准号:10466708
-
项目类别:
-
资助金额:$138.75万
-
财政年份:2021
-
负责人:Mary Katherine Hayden
-
依托单位:
CK20-004, Chicago Prevention and Intervention Epicenter III (CPIE-III)
-
批准号:10402237
-
项目类别:
-
资助金额:$169.73万
-
财政年份:2021
-
负责人:Mary Katherine Hayden
-
依托单位:
Chicago Prevention and Intervention Epicenter II (CPIE-II)
-
批准号:9338037
-
项目类别:
-
资助金额:$49.88万
-
财政年份:2016
-
负责人:Mary Katherine Hayden
-
依托单位:
Chicago Prevention and Intervention Epicenter II (CPIE-II)
-
批准号:10192603
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2016
-
负责人:Mary Katherine Hayden
-
依托单位:
国内基金
海外基金
登录
查看更多内容
新型蒽酚类化合物XYD004通过激活AHR缓解银屑病的作用及机制研究
-
批准号:2025JJ60573
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:蒋骞
-
依托单位:
tiRNA-Val-TAC-004在胃癌进展中的作用机制及标志物价值研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:付敏
-
依托单位:
环状RNA hsa_circSERPINE2_004介导MSC衰老在老年性骨质 疏松症发病中的作用及其机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:旺姗
-
依托单位:
ADRQβ-004疫苗靶向α1D-AR调节交感神经失衡与改善肺动脉重构的机制研究
-
批准号:82070522
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:邱志华
-
依托单位:
CsERF004调控黄瓜双抗性分子机制的研究
-
批准号:31801871
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:刘东
-
依托单位:
Snail/p53结合抑制剂SN004的抗肿瘤作用及分子机制研究
-
批准号:81803033
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:李红玫
-
依托单位:
以CKLF1为新型药物靶标的发现及其抗缺血性损伤的系统性药理学研究
-
批准号:81730096
-
项目类别:重点项目
-
资助金额:290.0万元
-
批准年份:2017
-
负责人:陈乃宏
-
依托单位:
SMIP004/SMIP004-7系列线粒体抑制剂作用机制及应用于去势抵抗性前列腺癌治疗的潜力研究
-
批准号:81773771
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2017
-
负责人:Dieter A. Wolf
-
依托单位:
新型脑保护剂H004及其活性葡萄糖醛酸代谢产物的脑转运代谢机制及药代-药效学研究
-
批准号:81603190
-
项目类别:青年科学基金项目
-
资助金额:17.3万元
-
批准年份:2016
-
负责人:盛莉
-
依托单位:
木质纤维素水解液中抑制剂对发酵性丝孢酵母T.fermentans HWZ004细胞生长和油脂积累的影响规律及其机理研究
-
批准号:31071559
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2010
-
负责人:吴虹
-
依托单位: